Preprint Article Version 2 Preserved in Portico This version is not peer-reviewed

Side Chain-modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity

Version 1 : Received: 24 May 2023 / Approved: 26 May 2023 / Online: 26 May 2023 (04:12:31 CEST)
Version 2 : Received: 30 May 2023 / Approved: 1 June 2023 / Online: 1 June 2023 (07:42:34 CEST)

A peer-reviewed article of this Preprint also exists.

Fan, D.; Wang, B.; Stelitano, G.; Savková, K.; Riabova, O.; Shi, R.; Wu, X.; Chiarelli, L.R.; Mikušová, K.; Makarov, V.; Lu, Y.; Hong, Y.; Qiao, C. Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity. Biomedicines 2023, 11, 1975. Fan, D.; Wang, B.; Stelitano, G.; Savková, K.; Riabova, O.; Shi, R.; Wu, X.; Chiarelli, L.R.; Mikušová, K.; Makarov, V.; Lu, Y.; Hong, Y.; Qiao, C. Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity. Biomedicines 2023, 11, 1975.

Abstract

Tuberculosis (TB) is a leading infectious disease with serious antibiotic resistance. The benzothiazinone (BTZ) scaffold PBTZ169, an inhibitor of the decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1) in Mycobacterium tuberculosis (Mtb), showed anti-TB potential in animal model and piloted clinical tests. Although highly potent, the BTZ type DprE1 inhibitors in general shows extremely low aqueous solubility, which adversely affect the drug like property. To improve the compounds physiochemical properties, we generated a series of BTZ analogues. Several optimized compounds had MIC values against Mtb in single digit nanomolar. The representative compound 37 displayed improved solubility and bioavailability compared to the lead compound. Additionally, compound 37 shows Mtb-killing ability in an acute infection mouse model.

Keywords

Anti-tubercular agents; DprE1 inhibitor; Structure activity relationship; in vivo activity

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (1)

Comment 1
Received: 1 June 2023
Commenter: Vadim Makarov
Commenter's Conflict of Interests: Author
Comment: We made some small changes and correct English. 
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.